The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.
Open accessAbstract
Increased expression of wild-type p53 in response to DNA damage arrests cells late in the G1 stage of the cell cycle by stimulating the synthesis of inhibitors of cyclin-dependent kinases, such as p21/WAF1. To study the effects of p53 without the complication of DNA damage, we used tetracycline to regulate its expression in MDAH041 human fibroblasts that lack endogenous p53. When p53 is expressed at a level comparable to that induced by DNA damage in other cells, most MDAH041 cells arrested in G1, but a significant fraction also arrested in G2/M. Cells released from a mimosine block early in S phase stopped predominantly in G2/M in the presence of p53, confirming that p53 can mediate arrest at this stage, as well as in G1. In these cells, there was appreciable induction of p21/WAF1. MDAH041 cells arrested by tetracycline-regulated p53 for as long as 20 days resumed growth when the p53 level was lowered, in striking contrast to the irreversible arrest mediated by DNA damage. Therefore, irreversible arrest must involve processes other than or in addition to the interaction of p53-induced p21/WAF1 with G1 and G2 cyclin-dependent kinases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“P53 uses cell cycle checkpoints to induce G1/S142, 143 and G2/M cell cycle arrest.144”
From Census and evaluation of p53 target genes (2017) · cites this paper as [144]
Citations
Cites
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,318
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,911
Cited by
Sorted by citations
Items 501–600 of 856
Inducing cancer cell death by targeting transcription factors
Kim, R., Tanabe, K., Emi, M., Uchida, Y., Inoue, H., & Toge, T. (2003) · Anti-Cancer Drugs · doi:10.1097/00001813-200301000-00002 · Cited by 23
8-Cl-cAMP Affects Glioma Cell-Cycle Kinetics and Selectively Induces Apoptosis
Grbovic, O. M., Jović, V., Ruždijić, S., Pejanovic, V. M., Rakić, L., & Kanazir, S. (2002) · Cancer Investigation · doi:10.1081/cnv-120005913 · Cited by 23
Schlatter, S., Bailey, J. E., & Fussenegger, M. (2001) · Biotechnology and Bioengineering · doi:10.1002/bit.1189 · Cited by 23
Targeting FoxM1 Effectively Retards p53-Null Lymphoma and Sarcoma
Wang, Z., Zheng, Y., Park, H.-J., Li, J., Carr, J. R., Chen, Y., Kiefer, M. M., Kopanja, D., Bagchi, S., Tyner, A. L., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0903 · Cited by 22
Suppression of angiogenesis by atmospheric pressure plasma in human aortic endothelial cells
Gweon, B., Kim, H., Kim, K., Kim, M., Shim, E., Kim, S., Choe, W., & Shin, J. H. (2014) · Applied Physics Letters · doi:10.1063/1.4870623 · Cited by 22
Wu, J., Chen, W., Yin, Y., Zheng, Z., & Zou, G. (2014) · BioMetals · doi:10.1007/s10534-014-9710-2 · Cited by 22
Li, G., & Qian, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172478 · Cited by 22
Abroudi, A. S., Samarasinghe, S., & Kulasiri, D. (2017) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2017.06.018 · Cited by 22
Pettinato, A. M., Yoo, D., VanOudenhove, J., Chen, Y., Cohn, R. L., Ladha, F. A., Yang, X., Thakar, K., Romano, R., Legere, N., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2021.109088 · Cited by 22
The effect of glutamine on A549 cells exposed to moderate hyperoxia
Ogunlesi, F. O., Cho, C., & McGrath‐Morrow, S. A. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2003.10.008 · Cited by 22
Johnson, N. F., & Jaramillo, R. J. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.97105s51143 · Cited by 22
Rotavirus infection induces G1 to S phase transition in MA104 cells via Ca+2/Calmodulin pathway
Bhowmick, R., Banik, G., Chanda, S. D., Chattopadhyay, S., & Chawla‐Sarkar, M. (2014) · Virology · doi:10.1016/j.virol.2014.03.001 · Cited by 21
Equol induced apoptosis via cell cycle arrest in human breast cancer MDA-MB-453 but not MCF-7 cells
Kim, T., & Choi, E. J. (2008) · Molecular Medicine Reports · doi:10.3892/mmr.1.2.239 · Cited by 21
Dual Regulatory Roles of Human AP-Endonuclease (APE1/Ref-1) in CDKN1A/p21 Expression
Sengupta, S., MITRA, S. P., & Bhakat, K. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068467 · Cited by 21
Libério, M. S., Sadowski, M. C., Davis, R. A., Rockstroh, A., Vasireddy, R. S., Lehman, M., & Nelson, C. C. (2015) · Oncotarget · doi:10.18632/oncotarget.6267 · Cited by 21
Zhang, Y., Srinivasan, B., Xing, C., & Lü, J. (2012) · PubMed · Cited by 21
Targeting the CINful genome: Strategies to overcome tumor heterogeneity
Cunningham, C. E., MacAuley, M. J., Yadav, G., Vizeacoumar, F. S., Freywald, A., & Vizeacoumar, F. J. (2019) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2019.02.006 · Cited by 19
Pospı́šilová, Š., Brázda, V., Amrichová, J., Kamermeierová, R., Paleček, E., & Vojtěšek, B. (2000) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00246-x · Cited by 21
C-terminus of p53 is required for G2 arrest
Nakamura, S., Gomyo, Y., Roth, J. A., & Mukhopadhyay, T. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205251 · Cited by 21
Fard, S. S., Jarrı́n, M., Boije, H., Fillon, V., All‐Eriksson, C., & Hallböök, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059133 · Cited by 20
Xu, X., Chen, Y., Zhang, X., Zhang, R., Chen, X., Liu, S.-L., & Sun, Q. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-6301 · Cited by 20
Shirai, Y., Shiba, H., Iwase, R., Haruki, K., Fujiwara, Y., Furukawa, K., Uwagawa, T., Ohashi, T., & Yanaga, K. K. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.034 · Cited by 20
Xu, H., Chen, Z., Li, H., Zhou, L., Liu, F., Lv, Y., & Liu, J. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.11.015 · Cited by 20
Alajez, N. M., Mocanu, J. D., Shi, W., Chia, M. C., Breitbach, C. J., Hui, A. B., Knowles, S., Bell, J. C., Busson, P., Takada, K., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4134 · Cited by 20
Chen, H., Goodus, M. T., de Toledo, S. M., Azzam, E. I., Levison, S. W., & Souayah, N. (2015) · ASN NEURO · doi:10.1177/1759091415578026 · Cited by 21
Chou, Y.-T., Koh, Y., Nagabhushanam, K., Ho, C., & Pan, M. (2021) · Molecules · doi:10.3390/molecules26164884 · Cited by 20
Huang, C., Yang, S.-H., Huang, S.-M., Lin, C.-M., Chien, C., Chen, Y., Lee, C., Wu, H.-H., & Chang, C. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-82 · Cited by 20
Kumari, R., V, Li, H., Haudenschild, D. R., Fierro, F. A., Carlson, C. S., Overn, P., Gupta, L., Gupta, K., Nolta, J. A., Yik, J. H. N., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs254 · Cited by 20
Mouse DDA3 gene is a direct transcriptional target of p53 and p73
Hsieh, S., Lo, P., & Wang, F.-F. (2002) · Oncogene · doi:10.1038/sj.onc.1205417 · Cited by 20
Castro, M. E., Guijarro, M. V., Moneo, V., & Carnero, A. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20079 · Cited by 20
Berg, R. W., Werner, M., Ferguson, P. J., Postenka, C. O., Vincent, M. D., Koropatnick, J. D., & Behrend, E. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29405-2 · Cited by 20
Alteration in p53 pathway and defect in apoptosis contribute independently to cisplatin-resistance
Ségal-Bendirdjian, E., Mannone, L., & Jacquemin‐Sablon, A. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400357 · Cited by 20
Fukuda, R., Suico, M. A., Koyama, K., Omachi, K., Kai, Y., Matsuyama, S., Mitsutake, K., Taura, M., Morino‐Koga, S., Shuto, T., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.442442 · Cited by 19
Duke, K. S., Thompson, E. A., Ihrie, M. D., Taylor-Just, A. J., Ash, E. A., Shipkowski, K. A., Hall, J. R., Tokarz, D. A., Cesta, M. F., Hubbs, A. F., et al. (2018) · Nanotoxicology · doi:10.1080/17435390.2018.1502830 · Cited by 19
Rasmussen, R., Christensen, K. V., Holm, R., & Nielsen, C. U. (2018) · Genomics · doi:10.1016/j.ygeno.2018.10.014 · Cited by 21
Peptide-based vectors mediated by avidin–biotin interaction for tumor targeted gene delivery
Qu, W., Qin, S., Kuang, Y., Zhuo, R., & Zhang, X. (2013) · Journal of Materials Chemistry B · doi:10.1039/c3tb00226h · Cited by 19
Barr, M. P., Gray, S. G., Hoffmann, A. C., Hilger, R. A., Thomale, J., O’Flaherty, J. D., Fennell, D. A., Richard, D., O’Leary, J. J., & O’Byrne, K. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054193 · Cited by 19
Agarwal, M. K., Amin, A. R. M. R., & Agarwal, M. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2835 · Cited by 19
Self-citationLee, L. H., Moh, M. C., Zhang, T., & Shen, S. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22215 · Cited by 19
Kim (2009) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000344 · Cited by 19
Rivu, S. F., Apu, M. N. H., Shabnaz, S., Nahid, N. A., Islam, M. R., Al-Mamun, M. M. A., Nahar, Z., Rabbi, S. N. I., Ahmed, M. U., Islam, M. S., et al. (2017) · Cancer Epidemiology · doi:10.1016/j.canep.2017.05.005 · Cited by 19
Li, X., Jiang, Z., Feng, J., Zhang, X., Wu, J., & Chen, W. (2017) · Oncotarget · doi:10.18632/oncotarget.18705 · Cited by 20
Enhanced radiosensitization of p53 mutant cells by oleamide
Lee, Y.-J., Chung, D.-Y., Lee, S., Jhon, G. J., & Lee, Y. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.11.033 · Cited by 19
Gene Therapy for Tumors of the Central Nervous System
Chung, R. Y., & Chiocca, E. A. (1998) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30262-x · Cited by 19
Studies on modulation of the activity of tumor suppressor protein p53
Kadaja, L. (2004) · DSpace repository (University of Tartu) · Cited by 19
The Molecular Mechanisms of Protective Role of Se on the G2/M Phase Arrest of Jejunum Caused by AFB1
Fang, J. S., Yin, H., Zheng, Z., Zhu, P., Peng, X., Zuo, Z., Cui, H., Zhou, Y., Ouyang, P., Geng, Y., et al. (2017) · Biological Trace Element Research · doi:10.1007/s12011-017-1030-2 · Cited by 18
p53 Frameshift Mutations Couple Loss-of-Function with Unique Neomorphic Activities
Tong, D. R., Zhou, W., Katz, C., Regunath, K., Venkatesh, D., Ihuegbu, C., Manfredi, J. J., Laptenko, O., & Prives, C. L. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0691 · Cited by 20
Vaccinia Virus Arrests and Shifts the Cell Cycle
Martin, C. K., Samolej, J., Olson, A. T., Bertoli, C., Wiebe, M. S., de Bruin, R. A. M., & Mercer, J. (2022) · Viruses · doi:10.3390/v14020431 · Cited by 18
Giant cell formation: the way to cell death or cell survival?
Horbay, R., & Stoika, R. S. (2011) · Open Life Sciences · doi:10.2478/s11535-011-0058-0 · Cited by 19
Characterization, expression and silencing by RNAi of p53 from Penaeus monodon
Dai, W., Qiu, L., Zhao, C., Fu, M., Ma, Z., Zhou, F., & Yang, Q. (2016) · Molecular Biology Reports · doi:10.1007/s11033-016-3988-9 · Cited by 18
Molinaro, C., Wambang, N., Bousquet, T., Vercoutter‐Edouart, A., Pélinski, L., Cailliau, K., & Martoriati, A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.837373 · Cited by 18
Ubiquitin proteasomal pathway mediated degradation of p53 in melanoma
Anwar, A., Norris, D. A., & Fujita, M. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.12.012 · Cited by 18
Liu, D., Huang, C., Kameyama, K., Hayashi, E., Yamauchi, A., Sumitomo, S., & Yokomise, H. (2002) · Cancer · doi:10.1002/cncr.10450 · Cited by 18
Stress gene activity in Hepg2 cells after sulfur mustard exposure
Schlager, J. J., & Hart, B. W. (2000) · Journal of Applied Toxicology · doi:10.1002/1099-1263(200009/10)20:5 · Cited by 18
Camptothecin and Zeocin Can Increase p53 Levels during All Cell Cycle Stages
Houser, S., Koshlatyi, S., Lu, T., Gopen, T., & Bargonetti, J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6073 · Cited by 18
O'Brien, K., Otto, K. A., & Rao, R. N. (1997) · Gene · doi:10.1016/s0378-1119(96)00583-5 · Cited by 18
Response of intracranial melanoma metastases to stereotactic radiosurgery
Gieger, M., Wu, J. K., Ling, M. N., Wazer, D. E., Tsai, J.-S., & Engler, M. J. (1997) · Radiation Oncology Investigations · doi:10.1002/(sici)1520-6823(1997)5:2 · Cited by 47
Klein, C., Céraline, J., Orvain, C., de la Salle, C., Bergerat, J., & Cazenave, J. (1997) · Biology of the Cell · doi:10.1016/s0248-4900(97)82317-9 · Cited by 18
Javvaji, K., Begum, G., Deshpande, S., Rana, R. K., & Misra, S. (2018) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00131 · Cited by 17
Misexpression ofBREgene in the developing chick neural tube affects neurulation and somitogenesis
Wang, G., Li, Y., Wang, X., Chuai, M., Chan, J. Y.-H., Lei, J., Münsterberg, A., Lee, K. K., & Yang, X. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-06-1144 · Cited by 17
Varriale, L., Coppola, E., Quarto, M., Veneziani, B. M., & Palumbo, G. A. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02239-1 · Cited by 17
Restoration of p53 Functions Protects Cells from Concanavalin A–Induced Apoptosis
Amin, A. R. M. R., Thakur, V. S., Gupta, K., Jackson, M. W., Harada, H., Agarwal, M. K., Shin, D. M., Wald, D. N., & Agarwal, M. L. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0732 · Cited by 18
Self-citationEpperly, M. W., Bray, J. A., Carlos, T. M., Prochownik, E. V., & Greenberger, J. S. (1999) · Radiation Research · doi:10.2307/3580046 · Cited by 17
Mechanisms of Cell Regeneration — From Differentiation to Maintenance of Cell Phenotype
Santos, A. R., Nascimento, V. A., Genari, S. C., & Lombello, C. B. (2014) · InTech eBooks · doi:10.5772/59150 · Cited by 18
Methionine sulfoxide reductase A regulates cell growth through the p53–p21 pathway
Choi, S. H., & Kim, H. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.145 · Cited by 17
Ludwig, K., & Parsons, S. J. (2011) · Genes & Cancer · doi:10.1177/1947601911402680 · Cited by 16
Weng, J., Bai, L., Lin, W.-Y., Chiu, C., Chen, Y., Chao, S.-W., & Feng, C. (2017) · Molecules · doi:10.3390/molecules22030472 · Cited by 16
Poon, R. Y. C. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6199-0 · Cited by 16
Malik, S., Saha, R., & Seth, P. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9523-7 · Cited by 16
Oncogenic H-ras induces cyclin B1 expression in a p53-independent manner
Santana, C., Ortega, E., & García-Carrancá, A. M. (2002) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(02)00172-0 · Cited by 16
Mirjolet, C., Mirjolet, J.-F., Barberi‐Heyob, M., Ramacci, C., & Merlin, J. (2002) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y02-069 · Cited by 16
McVean, M., & Liebler, D. C. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199903)24:3 · Cited by 101
DeSimone, J. N., Dolezalova, H., Redpath, J. L., & Stanbridge, E. J. (2000) · Radiation Research · doi:10.1667/0033-7587(2000)153[0131:pccaii]2.0.co;2 · Cited by 16
Hwang, S. J., Cha, J. Y., Park, S. G., Joe, G. J., Kim, H. M., Moon, H. B., Jeong, S. J., Lee, J. S., Shin, D. H., Ko, S. R., et al. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9413 · Cited by 16
Li, S., Wu, H., Chen, M., & Tollefsbol, T. O. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.05.001 · Cited by 15
Zhang, F., Ren, T., Wu, J., & Niu, J. (2015) · PubMed · Cited by 15
Shen, Y., Zhang, S., Huang, X., Chen, K., Shen, J., & Wang, Z. (2014) · BioMed Research International · doi:10.1155/2014/920275 · Cited by 15
Highlight: BRCA1 and BRCA2 proteins in breast cancer
Daniel, D. C. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10178 · Cited by 15
Delivery of Cell Cycle Genes to Block Astrocytoma Growth
Fueyo-Margareto, J., Gomez‐Manzano, C., Liu, T.-J., & Yung, W. K. A. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010661131403 · Cited by 15
Choi, J., Oh, Y., Kim, H. S., Kim, H., Ko, K. H., & Kim, W. (2002) · Glia · doi:10.1002/glia.10084 · Cited by 15
Anticancer mechanism of equol in 7,12-dimethylbenz(a)anthracene-treated animals
Choi, E. J. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1067 · Cited by 14
Kadioglu, O., Saeed, M. E. M., Mahmoud, N., Azawi, S. S. H., Mrasek, K., Liehr, T., & Efferth, T. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-02979-4 · Cited by 14
Mara, A., Carrasco, E., Ramrez, A., Jimnez, G., López‐Ruiz, E., Pern, M., Picon‐Ruiz, M., Campos, J., Boulaiz, H., & Antonio, J. (2012) · InTech eBooks · doi:10.5772/48267 · Cited by 14
Guan, R., Wen, X., Wu, J., Duan, R. C., Cao, H., Lam, S., Hou, D., Wang, Y., Hu, J., & Chen, Z. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1262-6 · Cited by 14
Wip1 contributes to cell homeostasis maintained by the steady-state level of Wtp53
Park, H. K., Panneerselvam, J., Dudimah, F. D., Dong, G.-Z., Sebastian, S., Zhang, J., & Fei, P. (2011) · Cell Cycle · doi:10.4161/cc.10.15.15923 · Cited by 14
Bhana, S., Hewer, A. J., Phillips, D. H., & Lloyd, D. R. (2008) · Mutagenesis · doi:10.1093/mutage/gen001 · Cited by 14
Oh, C., Lee, S. J., Park, S., & Moon, Y. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.696609 · Cited by 14
Kwon, Y. V., Shin, B. S., & Chung, I. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002081200 · Cited by 14
Li, C., Shridhar, K., & Liu, J. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1024483017549 · Cited by 14
Afkhami‐Ardakani, M., Hasanzadeh, S., Shahrooz, R., Delirezh, N., & Malekinejad, H. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13854 · Cited by 13
Nasab, N. T., Jalili‐Nik, M., Afshari, A. R., Farimani, A. R., & Soukhtanloo, M. (2023) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23486 · Cited by 13
Fard, S. S., All‐Ericsson, C., & Hallböök, F. (2013) · Cell Cycle · doi:10.4161/cc.27200 · Cited by 13
Pseudolaric acid B-induced apoptosis through p53-dependent pathway in human gastric carcinoma cells
Meng, A., & Jiang, L. (2009) · Journal of Asian Natural Products Research · doi:10.1080/10286020802573420 · Cited by 13
Necdin, a p53-Target Gene, Is an Inhibitor of p53-Mediated Growth Arrest
Lafontaine, J., Rodier, F., Ouellet, V., & Mes‐Masson, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031916 · Cited by 13
Human lung epithelial cells support human metapneumovirus persistence by overcoming apoptosis
Marsico, S., Caccuri, F., Mazzuca, P., Apostoli, P., Roversi, S., Lorenzin, G., Zani, A., Fiorentini, S., Giagulli, C., & Caruso, A. (2018) · Pathogens and Disease · doi:10.1093/femspd/fty013 · Cited by 13
Kubens, B. S., Niggemann, B., & Zänker, K. S. (2001) · Cancer Letters · doi:10.1016/s0304-3835(00)00651-0 · Cited by 13
García, J., Duran, A., Tabernero, M. D., Plaza, A. G., Corral, T., Najera, M. L., Gómez-Alonso, A., & Órfão, A. (2002) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.10006 · Cited by 13
Rigberg, D. A., Kim, F. S., Sebastian, J. L., Kazanjian, K. K., & McFadden, D. W. (1999) · Journal of Surgical Research · doi:10.1006/jsre.1999.5617 · Cited by 13
Park, C., Choi, B. T., Cheong, J., Moon, S., Kim, C., Lee, W. H., & Choi, Y. H. (2004) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2004.06.007 · Cited by 13
Eichhorn, K., & Jackson, S. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102295200 · Cited by 13
Metadata
- Authors
- Agarwal, M. L., Agarwal, A., Taylor, W. R., & Stark, G. R.
- Affiliations
- Cleveland Clinic (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1995-08-29
- Volume
- 92
- Issue
- 18
- Pages
- 8493-8497
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC41183
- OpenAlex
- W2016492849
- Semantic Scholar
- 0dec4b0f37cb7f12a6b4023ec829754468df3935
- Cited by
- 858
- References
- 30
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 13 · 2023: 22 · 2022: 12 · 2021: 18 · 2020: 24 · 2019: 21 · 2018: 22 · 2017: 40 · 2016: 29 · 2015: 28 · 2014: 33 · 2013: 25 · 2012: 25
- FWCI
- 17.64
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- p53, G2/M checkpoint, G1/S checkpoint, cell cycle arrest, p21, cyclin-dependent kinases, mimosine, DNA damage response
- MeSH terms
- Cell Cycle, Cell Division, Cell Line, Fibroblasts, Gene Expression Regulation, Humans, Genes, p53, Cyclins, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review